Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: John McCarthy who wrote (418)	3/1/1998 6:50:00 AM
From: James Baker	Read Replies (3) \| Respond to of 569

John, I see no way that skin applied med can get to the joint space unless it goes through the general circulation first. The transdermal route is really just a substitute for the oral route with medications (plus the patches have controlled sustained release features). I do not believe that there is any vascular or lymphatic drainage pattern that could allow joint treatment from skin application. So no more threat than the oral drug. Jim PS. I have been trying to answer these questions on BIOX and ANIK threads all morning on wife's fast MAC but keep getting "error can't load" reply. Frequent problem on the MAC. I have written webmistress but if anyone has a solution to the problem I sure would appreciate it. Thanks.